{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:40:25Z","timestamp":1756406425473,"version":"3.44.0"},"reference-count":9,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"DOI":"10.2340\/1651-226x.2025.44082","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:57:07Z","timestamp":1751443027000},"page":"857-858","source":"Crossref","is-referenced-by-count":0,"title":["The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status \u2013 a Danish nation-wide cohort study"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3120-8140","authenticated-orcid":false,"given":"Umar","family":"Aziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"117050","doi-asserted-by":"crossref","unstructured":"Rotbain EC, Rostgaard K, Kaastrup K, Mikkelsen SU, Hjalgrim H, Gr\u00f8nb\u00e6k K. The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status \u2013 a Danish nation-wide cohort study. Acta Oncol. 2025;64:623\u20139.","DOI":"10.2340\/1651-226X.2025.42422"},{"key":"117051","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/1651-226X.2025.42422","DOI":"10.2340\/1651-226X.2025.42422"},{"key":"117052","unstructured":"Alfian SD, Sukandar H, Lestari K, Abdulah R, Diantini A. Medication adherence in patients with type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 2022;186:110239."},{"key":"117053","unstructured":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110239"},{"key":"117054","doi-asserted-by":"crossref","unstructured":"Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9(5):293-303. https:\/\/doi.org\/10.1016\/S2213-8587(21)00050-4","DOI":"10.1016\/S2213-8587(21)00050-4"},{"key":"117055","unstructured":"Wang Y, Zhao Y, Li X, Chen Z, Liu H, Zhang T, et al. Obesity and risk of myelodysplastic syndromes and acute myeloid leukemia: a meta-analysis. Br J Cancer. 2022;126(3):530\u20138."},{"key":"117056","unstructured":"https:\/\/doi.org\/10.1038\/s41416-022-01722-2"},{"key":"117057","unstructured":"Kwok B, Hall JM, Witte ON, Levine RL, Jaiswal S, Ebert BL, et al. Inflammation and clonal hematopoiesis: a double-edged sword in hematologic malignancies. Blood Adv. 2020;4(11):2568\u20132577."},{"key":"117058","unstructured":"https:\/\/doi.org\/10.1182\/bloodadvances.2019000993"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44082\/50646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/44082\/50646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:02:49Z","timestamp":1756404169000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/44082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":9,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.44082","relation":{},"ISSN":["1651-226X"],"issn-type":[{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}